BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31870729)

  • 41. A cost comparison analysis of adjuvant radiation therapy techniques after breast-conserving surgery.
    Lanni T; Keisch M; Shah C; Wobb J; Kestin L; Vicini F
    Breast J; 2013; 19(2):162-7. PubMed ID: 23294184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaginal-cuff control and toxicity results of a daily HDR brachytherapy schedule in endometrial cancer patients.
    Ríos I; Rovirosa A; Ascaso C; Valduvieco I; Herreros A; Castilla L; Sabater S; Holub K; Pahisa J; Biete A; Arenas M
    Clin Transl Oncol; 2016 Sep; 18(9):925-30. PubMed ID: 26661111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time-Driven Activity-Based Costing: A Comparative Cost Analysis of Whole-Breast Radiotherapy Versus Balloon-Based Brachytherapy in the Management of Early-Stage Breast Cancer.
    Schutzer ME; Arthur DW; Anscher MS
    J Oncol Pract; 2016 May; 12(5):e584-93. PubMed ID: 27006360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single-institutional outcomes of adjuvant brachytherapy for Stage I endometrial cancer-Are outcomes consistent with randomized studies?
    Dohopolski MJ; Horne ZD; Gebhardt BJ; Glaser SM; Edwards RP; Kelley JL; Comerci JT; Olawaiye AB; Courtney-Brooks M; Berger JL; Sukumvanich P; Beriwal S
    Brachytherapy; 2018; 17(3):564-570. PubMed ID: 29426745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new short daily brachytherapy schedule in postoperative endometrial carcinoma. Preliminary results.
    Rovirosa Á; Ascaso C; Herreros A; Sánchez J; Holub K; Camarasa A; Sabater S; Oses G; García-Miguel J; Rivera Y; Arenas M
    Brachytherapy; 2017; 16(1):147-152. PubMed ID: 28029590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of air gaps around the cylinder by postinsertion computed tomography in vaginal cuff brachytherapy: A prospective series, systematic review, and meta-analysis.
    Sapienza LG; Ning MS; Pellizzon ACA; Jhingran A; Klopp AH; Lin LL; Kollmeier MA; Calsavara VF; Gutierrez NDS; Chojniak R; Gomes MJL; Baiocchi G
    Brachytherapy; 2019; 18(5):620-626. PubMed ID: 31160198
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MRI-Based Evaluation of the Vaginal Cuff in Brachytherapy Planning: Are We Missing the Target?
    Chapman CH; Prisciandaro JI; Maturen KE; Cao Y; Balter JM; McLean K; Jolly S
    Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):743-50. PubMed ID: 27020110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An analysis of simulation for adjuvant intracavitary high-dose-rate brachytherapy in early-stage endometrial cancer.
    Barney BM; MacDonald OK; Lee CM; Rankin J; Gaffney DK
    Brachytherapy; 2007; 6(3):201-6. PubMed ID: 17681241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can we shorten the overall treatment time in postoperative brachytherapy of endometrial carcinoma? Comparison of two brachytherapy schedules.
    Rovirosa A; Ascaso C; Arenas M; Sabater S; Herreros A; Camarasa A; Rios I; Holub K; Pahisa J; Biete A
    Radiother Oncol; 2015 Jul; 116(1):143-8. PubMed ID: 26194144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dosimetric advantages of using multichannel balloons compared to single-channel cylinders for high-dose-rate vaginal cuff brachytherapy.
    Hou X; Liu A; Zhang F; Wong J; Chen YJ
    Brachytherapy; 2016; 15(4):471-476. PubMed ID: 27066994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer.
    Dunn EF; Geye H; Platta CS; Gondi V; Rose S; Bradley KA; Anderson BM
    Gynecol Oncol; 2014 Jun; 133(3):494-8. PubMed ID: 24657301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Three-dimension anatomy-based planning optimization for high dose rate vaginal vault brachytherapy.
    Bahadur YA; Hassouna AH; Constantinescu CT; Naga AF; Ghasal NM; Elsayed ME
    Saudi Med J; 2012 Jun; 33(6):640-7. PubMed ID: 22729119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiotherapy practices in postoperative endometrial cancer: A survey of the ABS membership.
    Martell K; Doll C; Barnes EA; Phan T; Leung E; Taggar A
    Brachytherapy; 2019; 18(6):741-746. PubMed ID: 31521546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. External beam radiotherapy versus vaginal brachytherapy in patients with stage II endometrial cancer: a systematic review and meta-analysis.
    Narasimhulu DM; Cope A; Riaz IB; Petersen I; Cilby W; Langstraat C; Glaser G; Kumar A; Cappuccio S; Murad MH; West C; Mariani A
    Int J Gynecol Cancer; 2020 Jun; 30(6):797-805. PubMed ID: 32221021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrences and toxicity after adjuvant vaginal brachytherapy in Stage I-II endometrial cancer: A monoinstitutional experience.
    Perrucci E; Lancellotta V; Bini V; Zucchetti C; Mariucci C; Montesi G; Saccia S; Palumbo I; Aristei C
    Brachytherapy; 2016; 15(2):177-84. PubMed ID: 26727332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Do air gaps with image-guided vaginal cuff brachytherapy impact failure rates in patients with high-intermediate risk FIGO Stage I endometrial cancer?
    Richman AH; Patel AK; Rodríguez-López JL; Keller A; Vargo JA; Kim H; Sukumvanich P; Berger JL; Boisen MM; Edwards R; Taylor SE; Courtney-Brooks MB; Olawaiye A; Orr BC; Lesnock JL; Beriwal S
    Brachytherapy; 2021; 20(3):512-518. PubMed ID: 33384254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer.
    Jeans EB; Breen WG; Mullikin TC; Looker BA; Mariani A; Keeney GL; Haddock MG; Petersen IA
    Int J Gynecol Cancer; 2021 Jun; 31(6):859-867. PubMed ID: 33563642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
    Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification.
    Vargo JA; Kim H; Houser CJ; Berhane H; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
    Radiother Oncol; 2014 Oct; 113(1):126-31. PubMed ID: 25241996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy.
    Ng TY; Perrin LC; Nicklin JL; Cheuk R; Crandon AJ
    Gynecol Oncol; 2000 Dec; 79(3):490-4. PubMed ID: 11104626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.